Signaling Receptors for TGF-β Family Members.
暂无分享,去创建一个
[1] C. Heldin,et al. Signals and Receptors. , 2016, Cold Spring Harbor perspectives in biology.
[2] G. Blobe,et al. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling , 2015, Molecular biology of the cell.
[3] Lily Huang,et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A , 2015, Science Translational Medicine.
[4] C. Heldin,et al. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface , 2015, The Journal of cell biology.
[5] H. Gerhardt,et al. Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch , 2015, Nature Communications.
[6] T. Nheu,et al. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor* , 2015, The Journal of Biological Chemistry.
[7] X. Wang,et al. Regulatory MiR‐148a‐ACVR1/BMP circuit defines a cancer stem cell‐like aggressive subtype of hepatocellular carcinoma , 2015, Hepatology.
[8] J. Baselga,et al. Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer , 2014, Investigational New Drugs.
[9] J. Baselga,et al. Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study , 2014, Cardiovascular Toxicology.
[10] J. Baselga,et al. First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma , 2014, Clinical Cancer Research.
[11] G. Sapkota,et al. The emerging roles of deubiquitylating enzymes (DUBs) in the TGFβ and BMP pathways , 2014, Cellular signalling.
[12] G. Blobe,et al. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion , 2014, Molecular biology of the cell.
[13] Zhiguo Lin,et al. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. , 2014, Carcinogenesis.
[14] Xiwu Chen,et al. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling. , 2014, The Journal of clinical investigation.
[15] G. Blobe,et al. Role of TGF-β receptor III localization in polarity and breast cancer progression , 2014, Molecular biology of the cell.
[16] Jodie L Babitt,et al. MicroRNA-130a Is Up-regulated in Mouse Liver by Iron Deficiency and Targets the Bone Morphogenetic Protein (BMP) Receptor ALK2 to Attenuate BMP Signaling and Hepcidin Transcription* , 2014, The Journal of Biological Chemistry.
[17] C. Heldin,et al. Platelet-derived Growth Factor β-Receptor, Transforming Growth Factor β Type I Receptor, and CD44 Protein Modulate Each Other's Signaling and Stability* , 2014, The Journal of Biological Chemistry.
[18] G. Sapkota,et al. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling , 2014, Open Biology.
[19] Stephen Yip,et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma , 2014, Nature Genetics.
[20] Michael Brudno,et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations , 2014, Nature Genetics.
[21] K. Zen,et al. miR‐17 regulates the proliferation and differentiation of the neural precursor cells during mouse corticogenesis , 2014, The FEBS journal.
[22] C. Heldin,et al. TRAF6 Stimulates the Tumor-Promoting Effects of TGFβ Type I Receptor Through Polyubiquitination and Activation of Presenilin 1 , 2014, Science Signaling.
[23] Xiaochun Yu,et al. Crosstalk between TGF-β/Smad3 and BMP/BMPR2 signaling pathways via miR-17–92 cluster in carotid artery restenosis , 2013, Molecular and Cellular Biochemistry.
[24] K. Zen,et al. Role of miR-17 Family in the Negative Feedback Loop of Bone Morphogenetic Protein Signaling in Neuron , 2013, PloS one.
[25] F. Tsai,et al. BMPR1B Up-Regulation via a miRNA Binding Site Variation Defines Endometriosis Susceptibility and CA125 Levels , 2013, PloS one.
[26] G. Blobe,et al. Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. , 2013, The Journal of clinical investigation.
[27] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[28] Xiao-ming Meng,et al. Dragon (Repulsive Guidance Molecule RGMb) Inhibits E-cadherin Expression and Induces Apoptosis in Renal Tubular Epithelial Cells* , 2013, The Journal of Biological Chemistry.
[29] Craig Mickanin,et al. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. , 2013, Molecular cell.
[30] D. Bernstein,et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. , 2013, The Journal of clinical investigation.
[31] S. Murphy,et al. Retromer maintains basolateral distribution of the type II TGF-β receptor via the recycling endosome , 2013, Molecular biology of the cell.
[32] A. Burlingame,et al. Arginine Methylation Initiates BMP-Induced Smad Signaling. , 2013, Molecular cell.
[33] R. Chang,et al. MicroRNA‐140‐5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma , 2013, Hepatology.
[34] L. Wakefield,et al. Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.
[35] Y. Mishina,et al. Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation , 2013, Molecular and Cellular Biology.
[36] V. Kaartinen,et al. TGF-β-activated Kinase 1 (Tak1) Mediates Agonist-induced Smad Activation and Linker Region Phosphorylation in Embryonic Craniofacial Neural Crest-derived Cells* , 2013, The Journal of Biological Chemistry.
[37] S. Chien,et al. BMP receptor‐integrin interaction mediates responses of vascular endothelial Smad1/5 and proliferation to disturbed flow , 2013, Journal of thrombosis and haemostasis : JTH.
[38] Yue Jiang,et al. MicroRNA-181a Suppresses Mouse Granulosa Cell Proliferation by Targeting Activin Receptor IIA , 2013, PloS one.
[39] Jun Du,et al. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. , 2013, Molecular cell.
[40] R. Ravazzolo,et al. The Role of the 3′UTR Region in the Regulation of the ACVR1/Alk-2 Gene Expression , 2012, PloS one.
[41] D. Brazil,et al. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF&bgr; type II receptor with implications for nephropathic cell phenotypes , 2012, Journal of Cell Science.
[42] R. Bernards,et al. MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling , 2012, Cell.
[43] J. Qian,et al. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11 , 2012, Oncotarget.
[44] A. Hata,et al. Targeting the TGFβ signalling pathway in disease , 2012, Nature Reviews Drug Discovery.
[45] Yue Jiang,et al. MicroRNA‐145 suppresses mouse granulosa cell proliferation by targeting activin receptor IB , 2012, FEBS letters.
[46] R. Jain,et al. TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma , 2012, Proceedings of the National Academy of Sciences.
[47] J. Massagué. TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.
[48] B. Davis-Dusenbery,et al. Inhibition of MicroRNA-302 (miR-302) by Bone Morphogenetic Protein 4 (BMP4) Facilitates the BMP Signaling Pathway* , 2012, The Journal of Biological Chemistry.
[49] I. Keklikoglou,et al. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways , 2012, Oncogene.
[50] Stefan Knapp,et al. Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva , 2012, The Journal of Biological Chemistry.
[51] Wei-Guo Zhu,et al. MiR-135a functions as a selective killer of malignant glioma , 2012, Oncogene.
[52] Sha Huang,et al. MicroRNA‐100 regulates osteogenic differentiation of human adipose‐derived mesenchymal stem cells by targeting BMPR2 , 2012, FEBS letters.
[53] Y. Henis,et al. Oligomeric interactions of TGF‐β and BMP receptors , 2012, FEBS letters.
[54] Jeff Porter,et al. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor , 2012, Nature Cell Biology.
[55] G. Sapkota,et al. USP11 augments TGFβ signalling by deubiquitylating ALK5 , 2012, Open Biology.
[56] K. M. Mulder,et al. The TGFβ Receptor-interacting Protein km23-1/DYNLRB1 Plays an Adaptor Role in TGFβ1 Autoinduction via Its Association with Ras* , 2012, The Journal of Biological Chemistry.
[57] I. Leuschner,et al. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. , 2012, Carcinogenesis.
[58] P. ten Dijke,et al. Key role for ubiquitin protein modification in TGFβ signal transduction , 2012, Upsala journal of medical sciences.
[59] M. Goumans,et al. Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting* , 2012, The Journal of Biological Chemistry.
[60] Albert-László Barabási,et al. MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension: Results of a Network Bioinformatics Approach , 2012, Circulation.
[61] C. Heldin,et al. Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor β Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase* , 2012, The Journal of Biological Chemistry.
[62] J. Baselga,et al. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma , 2012, Nature Medicine.
[63] C. Bianco,et al. An evolving web of signaling networks regulated by Cripto-1 , 2012, Growth factors.
[64] A. Philip,et al. CD109‐mediated degradation of TGF‐β receptors and inhibition of TGF‐β responses involve regulation of SMAD7 and Smurf2 localization and function , 2012, Journal of cellular biochemistry.
[65] Leonardo Morsut,et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs , 2011, Nature Cell Biology.
[66] M. Scheideler,et al. MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2 , 2011, RNA biology.
[67] P. Wang,et al. TSC-22 Promotes Transforming Growth Factor β-Mediated Cardiac Myofibroblast Differentiation by Antagonizing Smad7 Activity , 2011, Molecular and Cellular Biology.
[68] A. Ristimäki,et al. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. , 2011, Gastroenterology.
[69] Wei Zhang,et al. A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China , 2011, Molecular Biology Reports.
[70] Robert L. Judson,et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells , 2011, Nature Biotechnology.
[71] C. Heldin,et al. TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer , 2011, Nature communications.
[72] A. Philip,et al. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. , 2011, Biochimica et biophysica acta.
[73] A. Hinck,et al. TGF‐β signalling is mediated by two autonomously functioning TβRI:TβRII pairs , 2011, The EMBO journal.
[74] Y. Glinka,et al. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. , 2011, Carcinogenesis.
[75] G. Fu,et al. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance , 2011, Journal of Cell Science.
[76] Wei Li,et al. TβRI/Alk5-independent TβRII signaling to ERK1/2 in human skin cells according to distinct levels of TβRII expression , 2011, Journal of Cell Science.
[77] P. Robinson,et al. Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity , 2010, Journal of Cell Science.
[78] Francis Impens,et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. , 2010, Molecular cell.
[79] P. Howe,et al. Type II Transforming Growth Factor-β Receptor Recycling Is Dependent upon the Clathrin Adaptor Protein Dab2 , 2010, Molecular Biology of the Cell.
[80] A. Atfi,et al. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor. , 2010, Cancer research.
[81] P. Lehner,et al. Identification of a Lysosomal Pathway Regulating Degradation of the Bone Morphogenetic Protein Receptor Type II , 2010, The Journal of Biological Chemistry.
[82] D. Mukhopadhyay,et al. Neuropilin-1 Mediates Divergent R-Smad Signaling and the Myofibroblast Phenotype* , 2010, The Journal of Biological Chemistry.
[83] K. Miyazono,et al. Smad7 Inhibits Transforming Growth Factor-β Family Type I Receptors through Two Distinct Modes of Interaction* , 2010, The Journal of Biological Chemistry.
[84] A. Hinck,et al. Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily* , 2010, The Journal of Biological Chemistry.
[85] Gerard C Blobe,et al. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. , 2010, Carcinogenesis.
[86] Zhen-ping Zhu,et al. Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells , 2010, Clinical Cancer Research.
[87] T. Clemens,et al. TGF-β type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling , 2010, Nature Cell Biology.
[88] J. Lieberman,et al. Molecular basis for antagonism between PDGF and the TGFβ family of signalling pathways by control of miR‐24 expression , 2010, The EMBO journal.
[89] M. Goumans,et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis , 2010, The Journal of experimental medicine.
[90] A. Hinck,et al. Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor. , 2009, Biochemistry.
[91] M. Goumans,et al. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP‐induced osteoblast differentiation and bone formation , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[92] C. Heldin,et al. The regulation of TGFβ signal transduction , 2009, Development.
[93] G. Blobe,et al. The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors. , 2009, Molecular biology of the cell.
[94] David Smith,et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. , 2009, Cancer research.
[95] Qianqian Wang,et al. Single-molecule imaging reveals transforming growth factor-β-induced type II receptor dimerization , 2009, Proceedings of the National Academy of Sciences.
[96] F. Chen,et al. Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling* , 2009, The Journal of Biological Chemistry.
[97] R. Derynck,et al. Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. , 2009, Developmental cell.
[98] Samy Lamouille,et al. TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. , 2009, Molecular cell.
[99] Sheng-Cai Lin,et al. Rock2 controls TGFβ signaling and inhibits mesoderm induction in zebrafish embryos , 2009, Journal of Cell Science.
[100] Min Xie,et al. TAK1 is an essential regulator of BMP signalling in cartilage , 2009, The EMBO journal.
[101] Maozhen Tian,et al. X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-β-mediated Nuclear Factor-κB Activation during Breast Cancer Progression* , 2009, The Journal of Biological Chemistry.
[102] Y. Henis,et al. Novel crosstalk to BMP signalling: cGMP‐dependent kinase I modulates BMP receptor and Smad activity , 2009, The EMBO journal.
[103] R. Speich,et al. Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 Pathway , 2009, Circulation research.
[104] G. Blobe,et al. The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42 , 2009, Proceedings of the National Academy of Sciences.
[105] Xin-Hua Feng,et al. Transforming Growth Factor β Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors* , 2009, Journal of Biological Chemistry.
[106] Y. Henis,et al. Different Domains Regulate Homomeric and Heteromeric Complex Formation among Type I and Type II Transforming Growth Factor-β Receptors* , 2009, Journal of Biological Chemistry.
[107] S. Mundlos,et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1 , 2009, Human mutation.
[108] C. Ouzounis,et al. Emergence, development and diversification of the TGF-β signalling pathway within the animal kingdom , 2009, BMC Evolutionary Biology.
[109] R. Derynck,et al. TGFβ‐stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro‐migratory TGFβ switch , 2009, The EMBO journal.
[110] H. You,et al. Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulation* , 2008, Journal of Biological Chemistry.
[111] G. Blobe,et al. Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC* , 2008, Journal of Biological Chemistry.
[112] C. Heldin,et al. The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner , 2008, Nature Cell Biology.
[113] M. Yamashita,et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.
[114] M. Howell,et al. Two highly related regulatory subunits of PP2A exert opposite effects on TGF-β/Activin/Nodal signalling , 2008, Development.
[115] C. Heldin,et al. Jcb: Report , 2022 .
[116] Mary E. Choi,et al. BAT3 Interacts with Transforming Growth Factor-β (TGF-β) Receptors and Enhances TGF-β1-induced Type I Collagen Expression in Mesangial Cells* , 2008, Journal of Biological Chemistry.
[117] Xin-Hua Feng,et al. Critical regulation of TGFβ signaling by Hsp90 , 2008, Proceedings of the National Academy of Sciences.
[118] R. Derynck,et al. The type I TGF-β receptor is covalently modified and regulated by sumoylation , 2008, Nature Cell Biology.
[119] M. Corada,et al. VE‐cadherin is a critical endothelial regulator of TGF‐β signalling , 2008, The EMBO journal.
[120] G. Blobe,et al. Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor* , 2008, Journal of Biological Chemistry.
[121] P. Dijke,et al. L- and S-endoglin differentially modulate TGFβ1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts , 2008, Journal of Cell Science.
[122] Joachim Nickel,et al. Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome* , 2008, Journal of Biological Chemistry.
[123] William P Schiemann,et al. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. , 2008, Carcinogenesis.
[124] L. Myeroff,et al. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells , 2008, Genes, chromosomes & cancer.
[125] A. Hinck,et al. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.
[126] V. Kaartinen,et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. , 2008, Blood.
[127] Huiling Xue,et al. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. , 2008, Blood.
[128] J. Massagué,et al. Genome-wide Impact of the BRG1 SWI/SNF Chromatin Remodeler on the Transforming Growth Factor β Transcriptional Program* , 2008, Journal of Biological Chemistry.
[129] M. Kwak,et al. TrkC binds to the type II TGF-β receptor to suppress TGF-β signaling , 2007, Oncogene.
[130] H. You,et al. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. , 2007, Carcinogenesis.
[131] P. Dijke,et al. Extracellular control of TGFβ signalling in vascular development and disease , 2007, Nature Reviews Molecular Cell Biology.
[132] Seong-Jin Kim,et al. TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling. , 2007, Cancer research.
[133] Y. Henis,et al. A unique element in the cytoplasmic tail of the type II transforming growth factor-beta receptor controls basolateral delivery. , 2007, Molecular biology of the cell.
[134] Uyen Tran,et al. MicroRNA control of Nodal signalling , 2007, Nature.
[135] Jing Qing,et al. TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .
[136] F. Colland,et al. The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor , 2007, The Journal of cell biology.
[137] K. Miyazono,et al. Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors* , 2007, Journal of Biological Chemistry.
[138] K. M. Mulder,et al. Requirement for the Dynein Light Chain km23-1 in a Smad2-dependent Transforming Growth Factor-β Signaling Pathway* , 2007, Journal of Biological Chemistry.
[139] H. Beppu,et al. Repulsive Guidance Molecule RGMa Alters Utilization of Bone Morphogenetic Protein (BMP) Type II Receptors by BMP2 and BMP4* , 2007, Journal of Biological Chemistry.
[140] A. Hata,et al. A Novel Regulatory Mechanism of the Bone Morphogenetic Protein (BMP) Signaling Pathway Involving the Carboxyl-Terminal Tail Domain of BMP Type II Receptor , 2007, Molecular and Cellular Biology.
[141] A. Gressner,et al. Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-β1 and BMP-7 Signaling* , 2007, Journal of Biological Chemistry.
[142] Hyun-A Seong,et al. NM23-H1 Tumor Suppressor Physically Interacts with Serine-Threonine Kinase Receptor-associated Protein, a Transforming Growth Factor-β (TGF-β) Receptor-interacting Protein, and Negatively Regulates TGF-β Signaling* , 2007, Journal of Biological Chemistry.
[143] W. Schiemann,et al. Src phosphorylates Tyr284 in tgf-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion , 2007 .
[144] Xu Cao,et al. Endofin acts as a Smad anchor for receptor activation in BMP signaling , 2007, Journal of Cell Science.
[145] L. David,et al. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.
[146] J. Coselli,et al. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation , 2007, Nature Clinical Practice Cardiovascular Medicine.
[147] Juswinder Singh,et al. A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection , 2007 .
[148] A. Meng,et al. The evolutionally conserved activity of Dapper2 in antagonizing TGF‐ß signaling , 2007 .
[149] B. Moeller,et al. The type III TGF-β receptor suppresses breast cancer progression , 2007 .
[150] K. Miyazono,et al. Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line , 2007, Cancer science.
[151] M. Asashima,et al. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. , 2006, Developmental cell.
[152] A. Heagerty,et al. Identification of Tctex2β, a Novel Dynein Light Chain Family Member That Interacts with Different Transforming Growth Factor-β Receptors* , 2006, Journal of Biological Chemistry.
[153] R. Akhurst,et al. TGF beta inhibition for cancer therapy. , 2006, Current cancer drug targets.
[154] W. Vale,et al. Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling , 2006, Molecular and Cellular Biology.
[155] George H. Thomas,et al. Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .
[156] G. Cesareni,et al. Conjugation to Nedd8 Instigates Ubiquitylation and Down-regulation of Activated Receptor Tyrosine Kinases* , 2006, Journal of Biological Chemistry.
[157] K. Rommel,et al. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys‐Dietz syndrome , 2006, Human mutation.
[158] William P Schiemann,et al. β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells , 2006, Breast Cancer Research.
[159] M. Reiss,et al. Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo , 2006, Clinical Cancer Research.
[160] Xiu-fen Lei,et al. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. , 2006, Cancer research.
[161] P. Lepage,et al. Identification of CD109 as part of the TGF‐β receptor system in human keratinocytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[162] K. Lewis,et al. Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions. , 2006, The Journal of biological chemistry.
[163] Raymond T Chung,et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.
[164] Marc K. Halushka,et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.
[165] Fumiko Itoh,et al. Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells , 2006, BMC Cell Biology.
[166] Kyong-Tai Kim,et al. Regulation of Transforming Growth Factor-β Signaling and PDK1 Kinase Activity by Physical Interaction between PDK1 and Serine-Threonine Kinase Receptor-associated Protein* , 2005, Journal of Biological Chemistry.
[167] Wolfram Kress,et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.
[168] J. Massagué,et al. Smad transcription factors. , 2005, Genes & development.
[169] P. Sorensen,et al. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-β signaling by inactivating the TGF-β type II receptor , 2005 .
[170] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[171] C. Heldin,et al. Non-Smad TGF-β signals , 2005, Journal of Cell Science.
[172] S. Shete,et al. Mutations in Transforming Growth Factor-&bgr; Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections , 2005, Circulation.
[173] J. Knowles,et al. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. , 2005, American journal of respiratory cell and molecular biology.
[174] A. de la Chapelle,et al. TGFBR1*6A may contribute to hereditary colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[175] A. Brivanlou,et al. DRAGON, a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.
[176] Jae Youn Yi,et al. Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase* , 2005, Journal of Biological Chemistry.
[177] Natasa Przulj,et al. High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells , 2005, Science.
[178] Yue Zhang,et al. Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity , 2005, Science.
[179] Ning Chen,et al. Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia , 2005, Human mutation.
[180] M. Manns,et al. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: Identification of five novel ALK1 and one novel ENG mutations , 2005, Human mutation.
[181] J. Wrana,et al. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP‐dependent dendritogenesis , 2004, The EMBO journal.
[182] Jonathan M. Yingling,et al. Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.
[183] Stefan Mundlos,et al. Modulation of GDF5/BRI‐b signalling through interaction with the tyrosine kinase receptor Ror2 , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[184] M. Weller,et al. SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo , 2004, Cancer Research.
[185] M. Goumans,et al. Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.
[186] J. Dennis,et al. Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.
[187] R. Hollingsworth,et al. CD44 modulates Smad1 activation in the BMP-7 signaling pathway , 2004, The Journal of cell biology.
[188] Ossama Tawfik,et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling , 2004, Nature Genetics.
[189] P. Pandolfi,et al. Cytoplasmic PML function in TGF-β signalling , 2004, Nature.
[190] R. Pagano,et al. Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11. , 2004, Molecular biology of the cell.
[191] W. Sebald,et al. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction , 2004, Biological chemistry.
[192] T. Akiyama,et al. Transcriptional regulation of the TGF-β pseudoreceptor BAMBI by TGF-β signaling , 2004 .
[193] Yusuke Nakamura,et al. Heterozygous TGFBR2 mutations in Marfan syndrome , 2004, Nature Genetics.
[194] H T Lynch,et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations , 2004, Journal of Medical Genetics.
[195] P. Thompson,et al. αvβ3 Integrin Interacts with the Transforming Growth Factor β (TGFβ) Type II Receptor to Potentiate the Proliferative Effects of TGFβ1 in Living Human Lung Fibroblasts* , 2004, Journal of Biological Chemistry.
[196] C. Heldin,et al. Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor β and Bone Morphogenetic Protein , 2004, Molecular and Cellular Biology.
[197] R. Coffey,et al. Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells. , 2004, Molecular biology of the cell.
[198] K. Miyazono,et al. Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells , 2004, The EMBO journal.
[199] K. Luo. Ski and SnoN: negative regulators of TGF-β signaling , 2004 .
[200] K. Mockaitis,et al. Arabidopsis kinome: after the casting , 2004, Functional & Integrative Genomics.
[201] Xu Cao,et al. GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor , 2004, The Journal of cell biology.
[202] Jonas Larsson,et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. , 2003, Molecular cell.
[203] E. Stanley,et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1 , 2003, The Journal of cell biology.
[204] Xiao-Fan Wang,et al. ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling , 2003, Science.
[205] Dean Y. Li,et al. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. , 2003, Developmental biology.
[206] K. Loveland,et al. Expression of Bambi is widespread in juvenile and adult rat tissues and is regulated in male germ cells. , 2003, Endocrinology.
[207] R. Weinberg,et al. Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos , 2003, Molecular and Cellular Biology.
[208] Jeffrey L. Wrana,et al. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.
[209] D. Arking,et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.
[210] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[211] K. M. Mulder,et al. A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein. , 2002, Molecular biology of the cell.
[212] L. Bourguignon,et al. Hyaluronan Promotes Signaling Interaction between CD44 and the Transforming Growth Factor β Receptor I in Metastatic Breast Tumor Cells* , 2002, The Journal of Biological Chemistry.
[213] A. Chawla,et al. TGFβ receptor internalization into EEA1-enriched early endosomes , 2002, The Journal of Cell Biology.
[214] T. Sanchez-Elsner,et al. Extracellular and Cytoplasmic Domains of Endoglin Interact with the Transforming Growth Factor-β Receptors I and II* , 2002, The Journal of Biological Chemistry.
[215] F. Lallemand,et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling , 2002, Oncogene.
[216] J. Doré,et al. Internalization-Dependent and -Independent Requirements for Transforming Growth Factor β Receptor Signaling via the Smad Pathway , 2002, Molecular and Cellular Biology.
[217] M. Shen,et al. Dual Roles of Cripto as a Ligand and Coreceptor in the Nodal Signaling Pathway , 2002, Molecular and Cellular Biology.
[218] M. Lin,et al. Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins. , 2002, Blood.
[219] Shashank Deep,et al. Crystal structure of the human TβR2 ectodomain–TGF-β3 complex , 2002, Nature Structural Biology.
[220] Anja Nohe,et al. The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.
[221] M. Reiss,et al. Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function. , 2002, The Journal of biological chemistry.
[222] M. Reiss,et al. Novel inactivating mutations of transforming growth factor‐β type I receptor gene in head‐and‐neck cancer metastases , 2001, International journal of cancer.
[223] J Kuriyan,et al. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. , 2001, Molecular cell.
[224] Xiang-Xi Xu,et al. The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway , 2001, The EMBO journal.
[225] Victor E. Velculescu,et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.
[226] Tomoki Chiba,et al. Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.
[227] M. Bitzer,et al. Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.
[228] R. Dildrop,et al. Bambi is coexpressed with Bmp-4 during mouse embryogenesis , 2001, Mechanisms of Development.
[229] P. Corris,et al. Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein tùype II receptor. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[230] A. Balmain,et al. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest , 2000 .
[231] J. Wrana,et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.
[232] A. Roberts,et al. Zebrafish nma is involved in TGFβ family signaling , 2000, Genesis.
[233] T. Kirsch,et al. Crystal structure of the BMP-2–BRIA ectodomain complex , 2000, Nature Structural Biology.
[234] Harold L. Moses,et al. STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling , 2000, Molecular and Cellular Biology.
[235] K. Lewis,et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling , 2000, Nature.
[236] K. Miyazono,et al. Smad6 Is a Smad1/5-induced Smad Inhibitor , 2000, The Journal of Biological Chemistry.
[237] A. Zargar,et al. Fibrodysplasia ossificans progressiva. , 1999, Annals of Saudi medicine.
[238] C. Niehrs,et al. Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.
[239] Morgan Huse,et al. Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12 , 1999, Cell.
[240] J. Wrana,et al. Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.
[241] Harold L. Moses,et al. Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling* , 1998, The Journal of Biological Chemistry.
[242] Liliana Attisano,et al. SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.
[243] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[244] R. Derynck,et al. Physical and Functional Interactions between Type I Transforming Growth Factor β Receptors and Bα, a WD-40 Repeat Subunit of Phosphatase 2A , 1998, Molecular and Cellular Biology.
[245] R. Frey,et al. Transforming growth factor β signaling through Smad1 in human breast cancer cells , 1998 .
[246] L. Germain,et al. TGF‐β receptor expression on human keratinocytes: A 150 kDa GPI‐anchored TGF‐β1 binding protein forms a heteromeric complex with type I and type II receptors , 1998, Journal of cellular biochemistry.
[247] H. Lodish,et al. Oligomeric Structure of Type I and Type II Transforming Growth Factor β Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane , 1998, The Journal of cell biology.
[248] Yigong Shi,et al. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF‐β receptors , 1998, The EMBO journal.
[249] K. Irie,et al. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development , 1998, The EMBO journal.
[250] C. Wernstedt,et al. Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling* , 1997, The Journal of Biological Chemistry.
[251] Jeffrey L. Wrana,et al. TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.
[252] C. Heldin,et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.
[253] J. Massagué,et al. Mechanism of TGFβ receptor inhibition by FKBP12 , 1997, The EMBO journal.
[254] R. Derynck,et al. A kinase subdomain of transforming growth factor‐β (TGF‐β) type I receptor determines the TGF‐β intracellular signaling specificity , 1997 .
[255] J. Wrana,et al. The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.
[256] R. Derynck,et al. The Type II Transforming Growth Factor-β Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues* , 1997, The Journal of Biological Chemistry.
[257] H. Lodish,et al. Positive and negative regulation of type II TGF‐β receptor signal transduction by autophosphorylation on multiple serine residues , 1997, The EMBO journal.
[258] K. Miyazono,et al. Phosphorylation of Ser165 in TGF‐beta type I receptor modulates TGF‐beta1‐induced cellular responses. , 1996 .
[259] P. Donahoe,et al. The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors , 1996, Cell.
[260] D. W. Johnson,et al. Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.
[261] J. Massagué,et al. Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling. , 1996, The EMBO journal.
[262] R. Derynck,et al. Homomeric interactions between type II transforming growth factor-beta receptors. , 1994, The Journal of biological chemistry.
[263] K. Miyazono,et al. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.
[264] Jeffrey L. Wrana,et al. Mechanism of activation of the TGF-β receptor , 1994, Nature.
[265] H. Lodish,et al. The types II and III transforming growth factor-beta receptors form homo-oligomers , 1994, The Journal of cell biology.
[266] J. Massagué,et al. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites , 1994, The Journal of cell biology.
[267] H. Lodish,et al. The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. , 1993, The Journal of biological chemistry.
[268] J. Massagué,et al. Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.
[269] J. Massagué,et al. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system , 1991, Cell.
[270] Merlin C. Thomas,et al. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. , 2014, Kidney international.
[271] J. Debus,et al. Blockade of TGF-beta signaling by the TGF β R-I kinase Inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma , 2011 .
[272] K. Mohammad,et al. TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. , 2011, Cancer research.
[273] K. Miyazono,et al. Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.
[274] Xin-Hua Feng,et al. Phospho-control of TGF-β superfamily signaling , 2009, Cell Research.
[275] Mary E. Choi,et al. Transforming Growth Factor-β (TGF-β1) Activates TAK1 via TAB1-mediated Autophosphorylation, Independent of TGF-β Receptor Kinase Activity in Mesangial Cells* , 2009, The Journal of Biological Chemistry.
[276] R. Derynck,et al. 2 TGF-β and the TGF-β Family , 2008 .
[277] In Ho Choi,et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva , 2006, Nature Genetics.
[278] M. O’Connor,et al. The TGF beta activated kinase TAK1 regulates vascular development in vivo. , 2006, Development.
[279] K. Rai,et al. Transforming growth factor-β (TGF-β)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-β receptor , 2004 .
[280] M. Reiss,et al. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. , 2003, The EMBO journal.
[281] S. Erzurum,et al. Pathobiology of pulmonary arterial hypertension. , 2002, The European respiratory journal.
[282] Y. Henis,et al. Transforming Growth Factor- Receptors Interact with AP2 by Direct Binding to 2 Subunit , 2002 .
[283] M. Humbert,et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.
[284] D. Marchuk,et al. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. , 2000, Developmental biology.
[285] Y. Henis,et al. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells. , 1999, The Journal of biological chemistry.
[286] D. W. Johnson,et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.
[287] R. Randall,et al. Transforming Growth Factor (cid:2) -Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth (cid:1) † , 2008 .